Journals / Türk Oftalmoloji Dergisi / 2009 / Cilt: 39 - Sayı: 1

Clinical course and treatment of a case with fungal endophthalmitis

Fungal endoftalmi saptanan bir olgunun tedavisi ve klinik seyri

Pages
52–55
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the presence of endogenous candida endophthalmitis, satisfactory outcomes may be obtained by systemic antifungal therapy even in cases of which vitrectomy could not be performed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The clinical course and treatment of a case with fungal endophthalmitis is described.
📊
Key Findings & Data:Visual acuity of a seventy-one year-old female, having underwent previously an intravitreal steroid injection for uveitis and subsequently an intravitreal amphotericin-B injection for candida endophthalmitis in another institute, was no light perception in the right eye and 0.16 and in the left eye.
💡
Conclusion & Impact:In the presence of endogenous candida endophthalmitis, satisfactory outcomes may be obtained by systemic antifungal therapy even in cases of which vitrectomy could not be performed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The clinical course and treatment of a case with fungal endophthalmitis is described. Visual acuity of a seventy-one year-old female, having underwent previously an intravitreal steroid injection for uveitis and subsequently an intravitreal amphotericin-B injection for candida endophthalmitis in another institute, was no light perception in the right eye and 0.16 and in the left eye. Fundus examination revealed significant vitritis and snowball in the left eye. Vitrectomy was not performed due to instabilitiy of systemic state. Ocular findings in the left eye regressed with systemic fluconazole and amphotericin-B treatment and visual acuity increased to 0.5 together with the disappearance of vitritis. In the presence of endogenous candida endophthalmitis, satisfactory outcomes may be obtained by systemic antifungal therapy even in cases of which vitrectomy could not be performed.

Özet

Bu çalışmada endojen fungal endoftalmi saptanan bir olgunun klinik seyri ve tedavisi tartışılmaktadır. Kandida albicans endokarditine eşlik eden ve başka bir merkezde her iki göze önceden üveit tanısıyla intravitreal steroid enjeksiyonu, daha sonradan kandida endoftalmisi nedeniyle intravitreal amfoterisin-B enjeksiyonu uygulanmış olan yetmişbir yaşındaki kadın hastanın başvuru sırasında görme keskinliği sağ gözde ışık hissi negatif ve sol gözde tashihle 0.16 düzeyinde idi. Fundus muayenesinde sol gözde belirgin vitritis ve alt yarıda kartopu lezyonu tespit edildi. Genel durum bozukluğu nedeniyle vitrektomi uygulanamadı. Sol gözdeki oküler bulgular sistemik flukonazol ve amfoterisin-B tedavisi ile gerileyerek görme keskinliğinin 0.5 düzeyine yükseldi ve vitritisin kaybolduğu izlendi. Vitrektomi uygulanamayan endojen kandida endoftalmi varlığında antifungal ajanlarla yapılan sistemik tedavi ile tatminkar sonuçlar alınabilmektedir.

🔖

Cite This Article

ALİMGİL, L., BAŞAR, D., YENEREL, N. M., TATLIPINAR, S., DİNÇ, U. A., GÖRGÜN, E. (2022). Clinical course and treatment of a case with fungal endophthalmitis. Türk Oftalmoloji Dergisi, Cilt: 39 - Sayı: 1, 52–55. https://ajindex.com/articles/638500

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Essman TF, Flynn HW Jr, Smiddy WE, Brod RD, Murray TG, Davis JL, Rubsamen PE: Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1997
  2. Khan FA, Sliam D, Khakoo RA: Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotheraphy 2007
  3. Jones DB: Theraphy of postsurgical fungal endophthalmitis. Ophthalmology 1978
  4. Smiddy WE: Treatment outcomes of endogenous endophthalmitis. Curr Opin Ophthalmol 1998
  5. Yağcı A, Pamukçu K, Tümbay E, Köse S, Ateş H: Endojen kandida retinitinde fluconazole tedavisi olgu sunusu. Retina-Vitreus 1993
  6. Şengün A, Gürelik G, Akbatur HH, Hasanreisoğlu B: Candida endoftalmisi nedeniyle uygulanan pars plana vitrektomilerden sonra retinal yırtık gelişimi. Retina-Vitreus 2000
  7. Schiedler V, Scott IU, Flynn HW Jr, Davis JL, Benz MS, Miller D: Culture-proven endogenous endophthalmitis: clinical features and visual acutiy outcomes. Am J Ophthalmol 2004,137:725-731. 8.King GA,-Zuravleff JJ, Yu VL: Fungal infections of the eye. In Clinical Mycology. Anaissie EJ, McGinnis MR, Pfaller MA, Eds. Philadelphia. Churchill-Livingstone 2002, 566-580. 9.Henderson DK, Edwards JE, Montgomerie JZ: Hemato genous Candida endophthalmitis in patients receiving pa-renteral hyperalimentation fluids. J Infect Dis 1981
  8. Martinez-Vazquez C, Fernandez-UIloa J, Bordon J, Spoena B, de la Fuente J, Ocampo A, Rubianes M: Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceeded and followed by antifungal therapy. Clin Infect Dis 1998
  9. Jones DB: Therapy of postsurgical fungal endophthalmitis. Trans Am Acad Ophthalmol Otolaryngol 1978
  10. Michelson PE, Stark W, Reeser F, Green WR: Endogenous Candida endophthalmitis. Int Ophthalmol Clin 191
  11. Christmas NJ, Smiddy WE: Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis. Ophthalmic Surg Lasers 1996
  12. Axelrod AJ, Peyman GA, Apple DJ: Toxicity of intravit-real injection of amphotericin B. Am J Ophthalmol 1973
  13. Souri EN, Green WR: Intravitreal amphotericin B toxicity. Am J Ophthalmol 1974
  14. Tremblay C, Barza M, Szoka F, Lahav M, Baum J: Reduced toxicity of liposome-associated amphotericin B injected intravitreally in rabbits. Invest Ophthalmol Vis Sci 1985
  15. Liu KR, Peyman GA, Khoobehi B: Efficacy of l